PL2645878T3 - Zapobieganie lub leczenie nadwagi i otyłości u pacjentów z cukrzycą typu 2 - Google Patents
Zapobieganie lub leczenie nadwagi i otyłości u pacjentów z cukrzycą typu 2Info
- Publication number
- PL2645878T3 PL2645878T3 PL11794255T PL11794255T PL2645878T3 PL 2645878 T3 PL2645878 T3 PL 2645878T3 PL 11794255 T PL11794255 T PL 11794255T PL 11794255 T PL11794255 T PL 11794255T PL 2645878 T3 PL2645878 T3 PL 2645878T3
- Authority
- PL
- Poland
- Prior art keywords
- overweight
- obesity
- prevention
- treatment
- type
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 206010033307 Overweight Diseases 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pediatric Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2010/050808 WO2012074375A1 (en) | 2010-12-01 | 2010-12-01 | Prevention or treatment of overweight and obesity in type 2 diabetic patients |
| EP11794255.7A EP2645878B1 (en) | 2010-12-01 | 2011-12-01 | Prevention or treatment of overweight and obesity in type 2 diabetic patients |
| PCT/NL2011/050826 WO2012074401A1 (en) | 2010-12-01 | 2011-12-01 | Prevention or treatment of overweight and obesity in type 2 diabetic patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2645878T3 true PL2645878T3 (pl) | 2018-04-30 |
Family
ID=43589662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11794255T PL2645878T3 (pl) | 2010-12-01 | 2011-12-01 | Zapobieganie lub leczenie nadwagi i otyłości u pacjentów z cukrzycą typu 2 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2645878B1 (pl) |
| CN (2) | CN107712873A (pl) |
| BR (1) | BR112013013112A2 (pl) |
| PL (1) | PL2645878T3 (pl) |
| RU (1) | RU2619223C2 (pl) |
| WO (2) | WO2012074375A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2777404A1 (en) * | 2013-03-15 | 2014-09-17 | Abbott Laboratories | Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women |
| EP2777403A1 (en) * | 2013-03-15 | 2014-09-17 | Abbott Laboratories | Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring |
| CN105394765B (zh) * | 2015-10-23 | 2018-07-20 | 深圳太太药业有限公司 | 一种具有减肥作用的组合物及其制备方法 |
| EP3184111A1 (en) * | 2015-12-21 | 2017-06-28 | Abbott Laboratories | Compositions comprising carbohydrates |
| EP3773013B1 (en) * | 2018-03-27 | 2025-04-30 | N.V. Nutricia | INSULIN REGULATION IN OVERWEIGHT OR OBESE ADULTS DURING LIFETIME INTERVENTION |
| CN108813262A (zh) * | 2018-07-02 | 2018-11-16 | 杭州相生相成科技有限公司 | 一种含dha藻油的复合益生菌固体饮料 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9824893D0 (en) * | 1998-11-12 | 1999-01-06 | Smithkline Beckman Corp | Novel method of treatment |
| CA2274414A1 (en) | 1999-06-11 | 2000-12-11 | Universite Laval | Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals |
| MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
| JP2006022068A (ja) | 2004-07-09 | 2006-01-26 | Meiji Milk Prod Co Ltd | 血清脂質代謝改善剤 |
| WO2006009437A2 (en) * | 2004-07-19 | 2006-01-26 | N.V. Nutricia | Use of aspartate for regulating glucose levels in blood |
| EP1853246A1 (en) * | 2005-02-17 | 2007-11-14 | Instituto del Metabolismo Celular, S.L. | L-aspartic acid for the treatment of problems in connection with the fat or glucose metabolism |
| CN101237874B (zh) * | 2005-07-05 | 2013-10-09 | 努特里希亚公司 | 碳水化合物成分及其在获得平稳的餐后葡萄糖响应中的应用 |
| CN100381063C (zh) | 2005-12-19 | 2008-04-16 | 余内逊 | 一种微米银蓝楂魔芋糖降脂减肥豆奶粉制备方法 |
| DE102006017611A1 (de) * | 2006-04-12 | 2007-10-25 | Südzucker AG Mannheim/Ochsenfurt | Kohlenhyrathaltige Sportgetränke |
| CN101297695A (zh) | 2008-06-17 | 2008-11-05 | 天津天狮生物发展有限公司 | 棒状增强能量营养的保健食品及其制备方法 |
| WO2010104374A1 (en) * | 2009-03-09 | 2010-09-16 | N.V. Nutricia | Nutritional composition inducing a postprandial endocrine response |
-
2010
- 2010-12-01 WO PCT/NL2010/050808 patent/WO2012074375A1/en not_active Ceased
-
2011
- 2011-12-01 BR BR112013013112A patent/BR112013013112A2/pt not_active Application Discontinuation
- 2011-12-01 CN CN201710952891.4A patent/CN107712873A/zh active Pending
- 2011-12-01 RU RU2013129518A patent/RU2619223C2/ru not_active IP Right Cessation
- 2011-12-01 WO PCT/NL2011/050826 patent/WO2012074401A1/en not_active Ceased
- 2011-12-01 CN CN2011800664793A patent/CN103338654A/zh active Pending
- 2011-12-01 EP EP11794255.7A patent/EP2645878B1/en not_active Revoked
- 2011-12-01 PL PL11794255T patent/PL2645878T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2619223C2 (ru) | 2017-05-12 |
| WO2012074375A1 (en) | 2012-06-07 |
| EP2645878B1 (en) | 2017-10-18 |
| CN107712873A (zh) | 2018-02-23 |
| RU2013129518A (ru) | 2015-01-10 |
| BR112013013112A2 (pt) | 2016-08-16 |
| WO2012074401A1 (en) | 2012-06-07 |
| CN103338654A (zh) | 2013-10-02 |
| EP2645878A1 (en) | 2013-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500892A1 (en) | Composition for use in the prevention and/or treatment of skin conditions and skin diseases | |
| IL221275A0 (en) | Sigma ligands for use in the prevention and /or treatment of postoperative pain | |
| SG10201609507TA (en) | Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions | |
| IL216154A0 (en) | Prevention and treatment of nosema disease in bees | |
| PL2614832T3 (pl) | Diagnostyka i leczenie stanu przedrzucawkowego | |
| IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
| ZA201403596B (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease | |
| ZA201201434B (en) | Use of metformin in cancer treatment and prevention | |
| IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
| LT3730132T (lt) | Kompozicija, skirta panaudoti pacientų su didele širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde | |
| PL2645878T3 (pl) | Zapobieganie lub leczenie nadwagi i otyłości u pacjentów z cukrzycą typu 2 | |
| EP2387407A4 (en) | MEDICAMENT FOR THE TREATMENT OF PAIN AND INFLAMMATION | |
| GB201115992D0 (en) | Inhibitors of Nox4 expression and/or Nox4 function and their use in the prevention and treatment of nerve injury and/or neuropathic pain | |
| GB0921803D0 (en) | Drug composition and its use in therapy | |
| SI2341900T1 (sl) | Medicinski proizvod in zdravljenje | |
| GB0919889D0 (en) | Drug composition and its use in therapy | |
| IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
| PL2475361T3 (pl) | N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego | |
| GB0921805D0 (en) | Drug composition and its use in therapy | |
| GB0919893D0 (en) | Drug composition and its use in therapy | |
| GB0910375D0 (en) | Drug composition and its use in therapy | |
| IL235066A0 (en) | Sorcs1 for use in the treatment of obesity and overweight | |
| PT2413934E (pt) | Domperidona a uma dose diária baixa para utilização no tratamento ou prevenção de uma doença associada a uma alteração na resposta imune | |
| GB201100230D0 (en) | GPR119 agonists for use in the treatment or prevention of overweight and obesity or for procuring weight-loss in humans | |
| GB201020304D0 (en) | Treatment and prevention of pain |